CVS Should Be Considered in Suspected Partial Molar Pregnancy for Diagnostic Clarification
Prenatal invasive testing for fetal karyotype should be considered in cases where it is unclear if the pregnancy is a complete mole with a coexisting normal twin or a possible singleton partial molar pregnancy 1. This recommendation comes from the most recent RCOG Green-top Guideline (2020), which specifically addresses this clinical scenario.
Clinical Context and Rationale
When you suspect a partial molar pregnancy, the diagnostic challenge lies in distinguishing between:
- A true partial mole (typically triploid)
- A complete mole with coexisting normal twin
- A normal pregnancy with placental abnormalities
- Mesenchymal hyperplasia of the placenta
CVS provides critical diagnostic information that ultrasound alone cannot definitively establish 1. The procedure allows for:
- Chromosomal analysis to confirm triploidy (characteristic of partial moles)
- Differentiation between partial mole and other pregnancy complications
- Early decision-making regarding pregnancy continuation
Safety Profile
The procedure-related risk of miscarriage following CVS is remarkably low in contemporary practice:
- Procedure-related risk: 0.20% (95% CI, -0.13 to 0.52%) 2
- When comparing similar risk profiles, the excess risk approaches -0.11% (95% CI, -0.29 to 0.08%), essentially negligible 2
- Success rates exceed 99.9% with experienced operators 3
These risks are substantially lower than historically quoted figures and should not be a barrier to obtaining crucial diagnostic information.
Practical Implementation
Refer to both a regional fetal medicine centre AND a GTD centre 1. This dual referral ensures:
- Expert ultrasound assessment
- Proper CVS technique by experienced operators
- Coordinated management planning
- Access to specialized pathology review
The 2025 EOTTD-ESGO-GCIG-ISSTD guidelines emphasize that ultrasound can be "highly suggestive but is not diagnostic" of molar pregnancy 4, reinforcing the value of tissue diagnosis through CVS.
Historical Evidence Supporting CVS Use
A case report from 1989 demonstrated successful first-trimester diagnosis of partial mole using combined ultrasound and CVS, with histopathologic examination showing hydropic villi and chromosomal studies confirming triploidy 5. This established the feasibility of the approach decades ago, and modern techniques have only improved safety profiles.
Key Caveats
- Do not biopsy suspected vaginal metastases - this can cause major hemorrhage 1
- Ensure the procedure is performed by operators experienced in CVS technique
- All tissue obtained should be sent to a GTD centre for expert pathological review 1
- Registration with a GTD centre represents minimum standard of care regardless of CVS results 1
Post-Procedure Management
Following CVS confirmation of partial mole:
- Proceed with uterine evacuation as clinically indicated
- Mandatory registration with GTD centre for hCG surveillance
- Risk of GTN after partial mole: 0.5-1.0% 1
- Cure rates approach 98-100% with proper follow-up 1
The diagnostic benefit of CVS in clarifying uncertain cases of suspected partial molar pregnancy substantially outweighs the minimal procedural risk, particularly when performed by experienced operators in appropriate referral centers 1, 2.